LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

Search

Omnicell Inc

Open

SectorGezondheidszorg

32.77 2.34

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

32.02

Max

32.79

Belangrijke statistieken

By Trading Economics

Inkomsten

13M

5.6M

Verkoop

21M

291M

K/W

Sectorgemiddelde

66.18

35.724

EPS

-0.151

Winstmarge

1.941

Werknemers

3,650

EBITDA

42M

30M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+30.06% upside

Dividenden

By Dow Jones

Volgende Winsten

29 okt 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

162M

1.5B

Vorige openingsprijs

30.43

Vorige sluitingsprijs

32.77

Nieuwssentiment

By Acuity

50%

50%

167 / 371 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bearish Evidence

Omnicell Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

2 sep 2025, 23:07 UTC

Acquisities, Fusies, Overnames

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2 sep 2025, 22:10 UTC

Belangrijke Marktbewegers

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2 sep 2025, 21:47 UTC

Winsten

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2 sep 2025, 16:52 UTC

Belangrijke Marktbewegers

CleanCore Solutions Shares Drop After $175 Million Private Investment

2 sep 2025, 22:47 UTC

Marktinformatie

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2 sep 2025, 21:40 UTC

Acquisities, Fusies, Overnames

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2 sep 2025, 21:07 UTC

Winsten

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2 sep 2025, 21:07 UTC

Winsten

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2 sep 2025, 21:05 UTC

Winsten

Couche-Tard 1Q Rev $17.35B >ATD.T

2 sep 2025, 21:05 UTC

Winsten

Couche-Tard 1Q Adj EPS 78c >ATD.T

2 sep 2025, 21:05 UTC

Winsten

Couche-Tard 1Q EPS 82c >ATD.T

2 sep 2025, 21:05 UTC

Winsten

Couche-Tard 1Q Net $782.5M >ATD.T

2 sep 2025, 21:00 UTC

Marktinformatie

ESG Roundup: Market Talk

2 sep 2025, 20:53 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2 sep 2025, 20:51 UTC

Acquisities, Fusies, Overnames

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2 sep 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

2 sep 2025, 20:27 UTC

Winsten

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2 sep 2025, 20:24 UTC

Acquisities, Fusies, Overnames

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2 sep 2025, 20:18 UTC

Acquisities, Fusies, Overnames

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2 sep 2025, 20:17 UTC

Acquisities, Fusies, Overnames

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2 sep 2025, 20:16 UTC

Acquisities, Fusies, Overnames

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2 sep 2025, 20:16 UTC

Acquisities, Fusies, Overnames

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2 sep 2025, 20:15 UTC

Acquisities, Fusies, Overnames

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2 sep 2025, 19:55 UTC

Winsten

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2 sep 2025, 19:50 UTC

Acquisities, Fusies, Overnames

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2 sep 2025, 19:09 UTC

Marktinformatie

Oil Futures Gain on Geopolitical Premium -- Market Talk

2 sep 2025, 19:00 UTC

Marktinformatie

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2 sep 2025, 18:12 UTC

Marktinformatie

Gold Pushes To New Record -- Market Talk

2 sep 2025, 17:04 UTC

Marktinformatie

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2 sep 2025, 16:57 UTC

Acquisities, Fusies, Overnames

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Peer Vergelijking

Prijswijziging

Omnicell Inc Prognose

Koersdoel

By TipRanks

30.06% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 41.75 USD  30.06%

Hoogste 55 USD

Laagste 32 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Omnicell Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

6 ratings

4

Buy

2

Hold

0

Sell

Technische score

By Trading Central

24.23 / 30.44Steun & Weerstand

Korte Termijn

Strong Bearish Evidence

Gemiddeld Termijn

Strong Bearish Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

167 / 371 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.